Moderate riskFDA DrugClass II

Novo Nordisk Wegovy semaglutide injection recalled for hair in prefilled pen

Novo Nordisk has recalled specific batches of Wegovy (semaglutide) 1 mg injection pens because hair was found inside prefilled syringes. This affects two lot numbers distributed nationwide. No injuries have been reported.

From the FDA notice · Read the official notice ↗

What to do

  1. Check if your Wegovy pens are lot #RZFYK06 or #RZFYA53 with expiration date 3/31/2027
  2. Do not use pens from these lots
  3. Contact your pharmacy or healthcare provider for a replacement or refund
  4. Call Novo Nordisk at 1-844-NOVO4ME (1-844-668-6463) if you have questions

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Wegovy (semaglutide) Injection, 1 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4501-14
Sold in
Nationwide
Made for
Adults (0 months and older)

This recall covers 2 products — see all of them.

Details

Units affected
N/A
Illnesses reported
None reported
Manufactured in
800 Scudders Mill Rd, N/A, Plainsboro, NJ, United States
Classification
Class II
Recall number
D-0245-2026

In the FDA's words

Description
Wegovy (semaglutide) Injection, 1 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4501-14 Presence of Particulate Matter: Hair was found in a prefilled syringe Lot #: RZFYK06, RZFYA53; Exp Date 3/31/2027 Distribution: Nationwide within the United States. Affected quantity: N/A
Hazard
Presence of Particulate Matter: Hair was found in a prefilled syringe

2 products in this recall

The agency lists each product separately. Check every one you might have.

Related topics

ParticulateDrugsSold nationwideMore from FDA Drug